Abstract: Green logistics is increasingly critical in mitigating the environmental impact of transportation. In this study, we address the Symmetric Green Volume Capacitated Vehicle Routing Problem ...

As OpenAI marks its tenth birthday in December 2025, it can celebrate becoming one of the world’s leading companies, worth perhaps as much as US$1 trillion (£750 billion). But it started as a ...

Location-driven applications continue to grow in complexity as businesses rely more heavily on real-time data, routing logic, and precise geospatial calculations. Whether it’s a delivery platform ...

What if building advanced AI-powered search systems didn’t require a team of engineers or months of development? Imagine uploading a few files, tweaking minimal settings, and instantly allowing your ...

The Gemini API improvements include simpler controls over thinking, more granular control over multimodal vision processing, and ‘thought signatures’ to improve function calling and image generation.

Nov 25 (Reuters) - Meta Platforms (META.O), opens new tab is in talks with Google to spend billions of dollars on the Alphabet (GOOGL.O), opens new tab-owned company's chips for use in its data ...

Google’s newest release is topping leaderboards and wowing rivals, but users aren’t dropping other models just yet. Google’s newest release is topping leaderboards and wowing rivals, but users ...

Microsoft Corp. is on track to surrender its position as the third-largest U.S. company thanks to Alphabet Inc.’s fresh shine in the eyes of investors. Back To Top ...

Pull requests help you collaborate on code with other people. As pull requests are created, they’ll appear here in a searchable and filterable list. To get started, you should create a pull request.

Rahul Naskar has years of experience writing news and features related to Android, phones, and apps. Outside the tech world, he follows global events and developments shaping the world of geopolitics.

Background: Early adoption of PCSK9 monoclonal antibodies and small-interfering RNA therapies depends on clinical-trial access. Yet communities with the highest cardiovascular burden—often ...